Improving the lives of patients with dementia and their caregivers

Building Tomorrow Together
- Innovation In Dementia

Roche

Type
Open Innovation

Area
Health

Purpose
Finding digital solutions to improve the quality of life of people with dementia and Alzheimer’s disease, as well as their families and caregivers.

Building Tomorrow Together – Innovation in Dementia, a collaborative innovation project by Roche, was created to bring together several key players in the health ecosystem in Portugal and around the world, with startups and innovators from all geographies, to work on a better future for patients with dementia.

The call for solutions included knowledge sharing and awareness around dementia and its challenges, early and improved diagnosis, as well as support to patients and caregivers, on a daily basis.

Renewable energy icon
Next Generation
Renewables
Energy management icon
Energy
Management/ Data
Asset Optimization icon
Asset
Optimisation
Thermal Solutions icon
Thermal
Solutions
Grid Planning icon
Grid Planning,
Optimisation and Stability
Energy Storage icon
Energy
Storage
Connected & Engaged Costumers icon
Connected & Engaged
Customers (B2B and B2C)
Mobility & Transport Electrification icon
Mobility & Transport
Electrification

Key Results

Pilot Projects

Care Providers

Solutions

Startups
Ausnet
CLP
edp
e-on
esb energy
Hydro Québec
innogy
Jera
origin
Tepco

Building Tomorrow Together – Innovation in Dementia

The Impact

Virtuleap and Lusíadas logo

Revolutionizing Neuropsychological Testing

Virtuleap is collaborating with Lusíadas Hospital in a virtual reality solution that digitalizes neuropsychological tests for Alzheimer’s patients. This innovative technology enhances diagnostic accuracy and supports more effective treatment planning for those living with Alzheimer’s disease.

NeoNeuro and Centro Hospital Entre Douro e Vouga logo

Simplifying Alzheimer’s Diagnosis

NeoNeuro’s pilot program with Centro Hospitalar de Entre Douro e Vouga aims to simplify the Alzheimer’s diagnosis process by using an innovative blood test. This test detects amyloid levels through neuro-aptamers, providing a faster and more accurate approach to diagnosing the disease.

Want to know more about
similar services?

Visit our Services page

It’s time to grow your business
with collaborative innovation.

I want to talk to the Beta-i team